Screening and follow-up of living kidney donors: A systematic review of clinical practice guidelines

Transplantation

Volumn 92, Issue 9, 2011, Pages 962-972

  Tong, Allison ^a,b   Chapman, Jeremy R ^c   Wong, Germaine ^a,b,c   De Bruijn, Jeanine ^a,d   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Clinical practice guidelines; Kidney transplantation; Living donor

Indexed keywords

BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONSENSUS; DIABETES MELLITUS; DONOR SELECTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MALIGNANT NEOPLASTIC DISEASE; MASS SCREENING; MENTAL HEALTH; MOTIVATION; NEPHROLITHIASIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION;

EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC;

EID: 80054980124     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182328276     Document Type: Review

References (50)

1. Truog RD. The ethics of organ donation by living donors. N Eng J Med 2005; 353: 444.
2. Reese PP, Caplan AL, Kesselhaim AS, et al. Creating a medical, ethical and legal framework for complex living kidney donors. Clin J Am Soc Nephrol 2006; 1: 1148.
3. Steiner WR, Gert B. Ethical selection of living kidney donors. Am J Kidney Dis 2000; 36: 677.
4. ANZDATA. Registry Report 2009. Adelaide: Australia and New Zealand Dialysis and Transplant Registry 2009.
5. NHS. Transplant activity in the UK. Bristol, UK: NHS Blood and Transplant 2009.
6. Davis CL, Delmonico FL. Living-donor kidney transplantation: A review of the current practices for the live donor. J Am Soc Nephrol 2005; 16: 2098.
7. Mandal AK, Snyder JJ, Gilbertson DT, et al. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation 2003; 75: 494.
8. Davis CL. Evaluation of the living kidney donor: Current perspectives. Am J Kidney Dis 2004; 43: 508.
9. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: Absence of proof is not proof of absence. Clin J AmSoc Nephrol 2006; 1: 885.
10. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801.
11. Boudville N, Ramesh Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
12. Clemens KK, Thiessen-Philbrook H, Parikh CR, et al. Psychosocial health of living kidney donors: A systematic review. Am J Transplant 2006; 6: 2965.
13. Mjoen G SK, Westlie L, Midtveedt K, et al. Quality of life in kidney donors. Am J Transplant 2011; 11: 1315.
14. Hayward RSA, Wilson MC, Tunis SR, et al. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? J Am Med Assoc 1995; 274: 570.
15. BTS. United Kingdom guidelines for living donor kidney transplantation. UK: British Transplantation Society/The Renal Association 2005.
16. CARI Guidelines. CARI Guidelines: Living kidney donor. Nephrology 2010; 15: s72.
17. CCDT. Enhancing living donation: A Canadian forum. Report and recommendations. Vancouver, British Columbia: The Canadian Council for Donation and Transplantation 2006.
18. Kalble T, Alcaraz A, Budde K, et al. Guidelines on renal transplantation. Arhem, The Netherlands: European Association of Urology 2009.
19. NHMRC. Organ and tissue donation by living donors. Guidelines for ethical practice for health professionals. Canberra: Australian Government. National Health and Medical Research Council 2007.
20. UNOS, OPTN. Living donors. Washington, DC: Organ Procurement and Transplantation Network, US Department of Health and Human Services, 2007, 2011.
21. WHO. WHOguiding principles on human cell, tissue and organ transplantation. Geneva, Switzerland: World Health Organisation, 2010.
22. Kasiske BL, Ravenscraft M, Ramos EL, et al. The evaluation of living renal transplant donors: Clinical practice guidelines. J Am Soc Nephrol 1996; 7: 2288.
23. EBPG. Section II: Evaluation and selection of donors. Nephrol Dial Transplant 2000; 15(suppl 7): 39.
24. Amsterdam Forum. A report of the Amsterdam forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 2005; 79 (2 suppl): s53.
25. Cohen J. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213.
26. Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med 2005; 37: 360.
27. Delmonico FL, Harmon WE. The use of a minor as a live kidney donor. Am J Transplant 2002; 2: 333.
28. Salvatierra O. Transplant physicians bear full responsibility for the consequences of kidney donation by a minor.AmJ Transplant 2002; 2: 297.
29. Ross LF, Thislethwaite JR. Minors as living solid-organ donors. Pediatrics 2008; 122: 454.
30. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305: 1545.
31. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-Measured and estimated glomerular filtration rate.NEng J Med 2006; 354: 2473.
32. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 2007; 7: 2333.
33. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000; 70: 1747.
34. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care 1992; 30: 473.
35. Ku JH. Health-related quality of life of living kidney donors: Review of the short form 36-health questionnaire. Transpl Int 2005; 18: 1309.
36. Lumsdaine JA, Wray A, Power MJ, et al. Higher quality of life in living donor kidney transplantation: Prospective cohort study. Transpl Int 2005; 18: 975.
37. Boivin A, Green J, van der Meulen J, et al. Why consider patients' preferences? A discourse analysis of clinical practice guideline developers. Med Care 2009; 47: 908.
38. Krahn M, Naglie G. The next step in guideline development: Incorporating patient preferences. JAMA 2008; 300: 436.
39. Tong A, Lopez-Vargas P, Howell M, et al. Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expect [Epub ahead of print, March 2011. doi:10.1111/j.1369-7625.2011.00676.x]
40. van Wersch A, Eccles M. Involvement of consumers in the development of evidence based clinical guidelines: Practical experiences from the North of England evidence based guideline development programme. Qual Health Care 2001; 10: 10.
41. Ferriman A. Becoming a live kidney donor. BMJ 2008; 336: 1374.
42. Weizer N, Weizman A, Sapira Z, et al. Suicide by related kidney donors following the recipients' death. Psychother Psychosom 1989; 51: 216.
43. Johnson EM, Anderson KJ, Jacobs C, et al. Long-term follow up of living kidney donors: Quality of life after donation. Transplantation 1999; 67: 717.
44. Delmonico FL. Exhanging kidneys-Advances in living donor transplantation. N Eng J Med 2004; 350: 1812.
45. Adams PL, Cohen DJ, Danovitch GM, et al. The nondirected livekidney donor: Ethical considerations and practice guidelines. Transplantation 2002; 74: 582.
46. Harpole LH, Kelley MJ, Schreiber G, et al. Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest 2003; 123: 7s.
47. Field MJ, Lohr KN. A provision instrument for assessing clinical practice guidelines. In: Field MJ, Lohr KN, eds. Guidelines for clinical practice. From development to use. Washington DC: National Academy Press 1992.
48. AGREE Collaboration. Appraisal of guidelines research and evaluation. London UK: The AGREE Collaboration at www. agreecollaboration.org, 2001.
49. Lopez-Olivo MA, Kallen MA, Ortiz Z, et al. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: A systematic review. Arthritis Rheum 2008; 59: 1625.
50. Graham ID, Calder LA, Herbert PC, et al. A comparison of clinical practice guideline appraisal instruments. Int J Technol Assess Health Care 2000; 16: 1024.